18 September 2019

KEMRI “assante sana” for a wonderful meeting!

The Pediatric Praziquantel Consortium looks back on a very inspiring and successful Consortium meeting in Kisumu, the third largest city in Kenya located by the shore of Lake Victoria.

Apart from twenty Team and Board members, representatives from the Kenya Ministry of Health, the University of Nairobi, the Japanese GHIT Fund and the Japan International Cooperation Agency joined the 3-day meeting (12-14 March) as honorary guests.

On the first day, the group was officially welcomed by KEMRI’s Director-General Prof. Kombe at the KEMRI Centre for Global Health Research facility, followed by a joint Team/Board meeting to discuss the progress of the project and the stages after the phase III clinical trial: registration and access. The second day, the group visited the Homa Bay District Hospital, one of the Phase III clinical trial sites (the other one is in Man, Côte d’Ivoire) where they met the local trial team and hospital staff and learned first-hand about some of the challenges associated with performing a clinical trial in an endemic country like Kenya. The trip to Homa Bay allowed the team to catch a glimpse of the many routine agricultural, domestic, and recreational activities, which constantly expose children and adults to infested water and the risk of Schistosoma infection. Throughout the meeting, but especially on day 3, Consortium members really appreciated the time to interact with each other and the guests at a professional, social and personal level.

Overall, the meeting provided the necessary inspiration and allowed the Consortium to deepen the existing ties necessary for the next step in the development program: the clinical Phase III trial.

Therefore, KEMRI “assante sana” for a wonderful meeting!

    

The photos above show some highlights from the Consortium Meeting in Kisumu, showing lab work, a work meeting and the clinic.